MALVERN, Pa. — Siemens Healthcare has announced that it recently submitted to the U.S. Food and Drug Administration (FDA) its premarket approval application (PMA) for the MAMMOMAT Inspiration® with Breast Tomosynthesis option.
Israeli imaging systems maker Dune Medical Devices touted the successful raise of $14 million in equity financing, looking to secure another $7 million before October to support its commercialization efforts.
Cancer detections systems maker VuCOMP announced this week that it won FDA approval for new computer-aided detection software, launching version 3.1 of its M-Vu CAD for mammography.
MASSDEVICE ON CALL — The majority of women who’ve had both breasts removed following a breast cancer diagnosis probably didn’t need to take such drastic measures, according to a new study.
Researchers from the University of Michigan Comprehensive Cancer Center reported that as much as 70% of women who opted for a double mastectomy following breast cancer did so despite a very low risk of recurrence.
Breast cancer experts are calling for a fresh look at routine mammography, warning that screening may not save lives and may instead lead to risky overdiagnoses.